MULAI XU focuses her practice on regulatory, compliance, and enforcement matters in China in the life sciences industry. She has experience in assisting life sciences companies on matters in connection with clinical trials, manufacturing, marketing authorization, imports/exports, distribution, and promotional/advertising activities. Mulai has also assisted multinational companies and their Chinese subsidiaries in internal compliance programs and investigations under the U.S. Foreign Corrupt Practices Act (FCPA), as well as China’s anti-bribery laws.
She is a native Chinese speaker and is fluent in English.